Bayer Healthcare Pharmaceuticals (Bayer) have announced the launch of a major new initiative, the global Bayer Ophthalmology Awards Program (BOAP).
The program encourages submissions from around the world and offers research grants to better understand, and therefore treat, optic diseases such as age-related macular degeneration and other retinal disorders. Rene Klemm, Bayer HealthCare General Manager Australia, said supporting these awards was another example of Bayer's commitment to furthering research and development in ophthalmology. "We are proud to support this exciting new program and with applications taken from around the world we urge Australian ophthalmologists and retinal specialists to get involved."
The Macular Degeneration Foundation welcomes this fantastic new initiative as an important step in the process towards saving the sight of Australians.
The deadline for applying to the GOAP for the 2012 awards cycle has been extended to 30 April, 2012.
Read more here.
26 Feburary 2012